---
provider: perplexity
model: sonar-deep-research
cached: false
start_time: '2026-01-03T18:58:51.903438'
end_time: '2026-01-03T19:01:03.722454'
duration_seconds: 131.82
template_file: templates/gene_research_go_focused.md
template_variables:
  organism: human
  gene_id: ATF4
  gene_symbol: ATF4
  uniprot_accession: P18848
  protein_description: 'RecName: Full=Cyclic AMP-dependent transcription factor ATF-4
    {ECO:0000305}; Short=cAMP-dependent transcription factor ATF-4 {ECO:0000305};
    AltName: Full=Activating transcription factor 4 {ECO:0000303|PubMed:2516827};
    AltName: Full=Cyclic AMP-responsive element-binding protein 2 {ECO:0000303|PubMed:1534408};
    Short=CREB-2 {ECO:0000303|PubMed:1534408}; Short=cAMP-responsive element-binding
    protein 2 {ECO:0000303|PubMed:1534408}; AltName: Full=Tax-responsive enhancer
    element-binding protein 67 {ECO:0000303|PubMed:1847461}; Short=TaxREB67 {ECO:0000303|PubMed:1847461};'
  gene_info: Name=ATF4 {ECO:0000303|PubMed:2516827, ECO:0000312|HGNC:HGNC:786}; Synonyms=CREB2
    {ECO:0000303|PubMed:1534408}, TXREB {ECO:0000303|PubMed:1847461};
  organism_full: Homo sapiens (Human).
  protein_family: Belongs to the bZIP family. .
  protein_domains: bZIP. (IPR004827); bZIP_sf. (IPR046347); bZIP_1 (PF00170)
provider_config:
  timeout: 600
  max_retries: 3
  parameters:
    allowed_domains: []
    reasoning_effort: medium
    search_domain_filter: []
    return_citations: true
    temperature: 0.0
citation_count: 52
---

## Question

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** P18848
- **Protein Description:** RecName: Full=Cyclic AMP-dependent transcription factor ATF-4 {ECO:0000305}; Short=cAMP-dependent transcription factor ATF-4 {ECO:0000305}; AltName: Full=Activating transcription factor 4 {ECO:0000303|PubMed:2516827}; AltName: Full=Cyclic AMP-responsive element-binding protein 2 {ECO:0000303|PubMed:1534408}; Short=CREB-2 {ECO:0000303|PubMed:1534408}; Short=cAMP-responsive element-binding protein 2 {ECO:0000303|PubMed:1534408}; AltName: Full=Tax-responsive enhancer element-binding protein 67 {ECO:0000303|PubMed:1847461}; Short=TaxREB67 {ECO:0000303|PubMed:1847461};
- **Gene Information:** Name=ATF4 {ECO:0000303|PubMed:2516827, ECO:0000312|HGNC:HGNC:786}; Synonyms=CREB2 {ECO:0000303|PubMed:1534408}, TXREB {ECO:0000303|PubMed:1847461};
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Belongs to the bZIP family. .
- **Key Domains:** bZIP. (IPR004827); bZIP_sf. (IPR046347); bZIP_1 (PF00170)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "ATF4" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'ATF4' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **ATF4** (gene ID: ATF4, UniProt: P18848) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

## Output

<think>
Let me plan my response to this comprehensive research query about ATF4 (P18848).

## Planning My Approach:

1. **Verification of Gene/Protein Identity**: I need to verify that ATF4 (P18848) is indeed a human transcription factor belonging to the bZIP family. From the search results, I can see extensive evidence confirming this is the correct protein.

2. **Major Themes to Cover**:
   - Molecular structure and DNA binding properties
   - Primary function as a transcription factor
   - Role in the integrated stress response (ISR)
   - Regulation and translation control mechanisms
   - Target genes and downstream functions
   - Cellular localization
   - Dimerization partners
   - Post-translational modifications
   - Biological processes (stress response, development, metabolism)
   - Applications and disease relevance

3. **Organization**:
   - Title and introduction
   - Structural architecture and DNA binding
   - The Integrated Stress Response
   - Translational regulation
   - Transcriptional targets and functions
   - Dimerization and protein-protein interactions
   - Regulation mechanisms (post-translational modifications)
   - Cellular localization and trafficking
   - Role in specific biological processes
   - Clinical significance and disease associations
   - Conclusion

4. **Sources Assessment**: The search results provide excellent coverage with recent reviews, primary literature, and structural/biochemical studies. I have sources from 2023-2024 as well as foundational earlier work.

Let me write a comprehensive 10,000+ word report now.
</think>

# Activating Transcription Factor 4 (ATF4): A Master Regulator of Cellular Stress Response and Metabolic Adaptation

## Overview and Introduction

**Activating Transcription Factor 4 (ATF4)**, encoded by the ATF4 gene on human chromosome 22, is a fundamental transcription factor that functions as the central executor of the **integrated stress response (ISR)**[1][2][7]. Known by several alternative names including cyclic AMP-responsive element-binding protein 2 (CREB-2), tax-responsive enhancer element-binding protein 67 (TaxREB67), and originally identified as a cAMP response element binding protein, ATF4 represents one of the most sophisticated examples of translational and transcriptional gene regulation in mammalian cells[2][4][21]. As a member of the basic region-leucine zipper (bZIP) family of transcription factors, ATF4 binds to cAMP response element (CRE) consensus sequences in the promoters and enhancers of target genes[2][4]. This comprehensive research report examines the molecular mechanisms, regulatory pathways, biological functions, and disease relevance of ATF4, synthesizing evidence from structural biology, biochemistry, cell biology, and clinical studies to elucidate how this single transcription factor orchestrates adaptive responses to diverse cellular stresses while simultaneously maintaining normal metabolic and developmental processes. The dual functionality of ATF4—serving as both a basal metabolic regulator during normal conditions and a master stress-response transcription factor during stress—exemplifies the elegant biological solutions that cells have evolved to maintain homeostasis in the face of environmental challenges.

## Structural Architecture and DNA Binding Specificity

### Basic-Leucine Zipper Domain Organization

ATF4 exhibits a characteristic modular architecture composed of distinct functional domains that enable its sophisticated regulation and target gene selectivity[3][29]. The protein consists of an extended N-terminal intrinsically disordered transactivation domain (TAD) spanning approximately residues 1-275, and a C-terminal conditionally ordered basic-leucine zipper (bZip) domain encompassing the DNA-binding basic region and the dimerization leucine zipper motif[3][29][60]. The bZip domain belongs to the broader bZIP superfamily of transcription factors, characterized by a stretch of basic amino acids that form direct contacts with DNA, positioned immediately adjacent to a region of heptad repeats creating a leucine zipper motif critical for protein-protein interactions[2][4]. The consensus DNA binding site recognized by ATF4 is the cAMP response element (CRE), with the canonical sequence 5'-GTGACGT[AC][AG]-3'[2][21], though ATF4 displays flexibility in recognizing asymmetric and palindromic CRE variants depending on its dimerization status and binding context[2][6].

Recent structural and biophysical studies have revealed that the secondary basic motif at the C-terminus of ATF4 (designated B2), which is conserved exclusively with its paralogue ATF5, plays a critical role in mediating interdomain coupling between the transactivation and bZip domains[3]. Through solution NMR spectroscopy and fluorescence polarization assays, researchers demonstrated that this B2 motif serves as the primary driver of transient long-range interactions between the TAD and bZip domains[3]. These intramolecular interactions fundamentally modulate DNA-binding activity and specificity—the presence of the TAD negatively impacts the bZip domain's ability to bind DNA nonspecifically, while paradoxically enhancing specificity for cognate CRE sequences[3]. Importantly, the isolated bZip domain exhibits equal affinity for both CRE and non-CRE DNA sequences, but the full-length ATF4 protein shows dramatically reduced binding to non-cognate sequences, indicating that the disordered TAD functions as a specificity filter[3]. Deletion of the C-terminal B2 motif abolishes this nonspecific binding suppression, highlighting how this conserved structural element precisely tunes DNA-binding selectivity[3].

### Modes of DNA Binding and Dimerization

ATF4 binds DNA through distinct mechanisms dependent on its dimerization status and binding partner identity[2][6]. When functioning as a homodimer, ATF4 recognizes palindromic CRE sequences, each monomer occupying one half of the palindromic site[2]. In contrast, ATF4 forms heterodimers with numerous bZIP proteins from families including C/EBP proteins, other ATF family members (ATF3, ATF5, ATF6), and AP-1 proteins (c-Jun, c-Fos, Fra1)[2][6][57]. These heterodimers bind asymmetric CRE sequences, with the DNA-binding specificity determined by the particular combination of bZIP partners[2][6]. Research using 270 different bZIP transcription factor pairs demonstrated that approximately 72% of bZIP heterodimer pairs bind sequences termed "conjoined half-sites," where the composite binding site consists of the characteristic half-site sequence from each monomer positioned in direct succession[57]. For ATF4-containing heterodimers, this means that the specific target genes regulated depend critically on which bZIP partner ATF4 has dimerized with, providing an elegant molecular mechanism for generating transcriptional specificity from a common upstream stress signal[2][6][57].

The bZIP domains of individual transcription factors within this family contain sufficient information to direct selective heterodimerization through an interhelical salt bridge rule, whereby positively charged residues (primarily lysine and arginine) on one helix interact with negatively charged residues (aspartate and glutamate) on the partner helix[33]. This electrostatic complementarity provides the specificity underlying bZIP heterodimerization, explaining why ATF4 preferentially forms certain heterodimeric combinations while excluding others[33]. ATF4 has been identified as preferentially dimerizing with members of the C/EBP family such as C/EBPβ, C/EBPγ, and C/EBPδ, as well as forming heterodimers with ATF3, JDP2, and other transcription factors[57]. Notably, the specific heterodimeric combination formed appears to be partially dependent on cellular context, stress type, and the relative abundance of potential dimerization partners within the nuclear compartment.

## The Integrated Stress Response Pathway

### eIF2α Phosphorylation as the Central Switch

ATF4 functions as the premier molecular effector of the integrated stress response (ISR), a conserved adaptive pathway activated when cells encounter diverse stress signals including endoplasmic reticulum (ER) stress, amino acid deprivation, mitochondrial dysfunction, oxidative stress, heme deficiency, and viral infection[7][10][11][21][28][40]. The ISR operates through a remarkably elegant molecular mechanism centered on the phosphorylation of eukaryotic initiation factor 2 alpha (eIF2α) at serine 51, catalyzed by one of four stress-responsive serine/threonine kinases: general control nonderepressible 2 (GCN2), protein kinase R-like endoplasmic reticulum kinase (PERK), protein kinase R (PKR), and heme-regulated inhibitor (HRI)[7][10][11][28][52]. Each kinase is activated by distinct stress stimuli with exquisite specificity—GCN2 responds to uncharged (deacylated) transfer RNA accumulation during amino acid starvation[7][8][11], PERK senses accumulation of misfolded proteins in the endoplasmic reticulum[7][11], PKR is activated by double-stranded RNA during viral infection[11], and HRI responds to heme deficiency[11][52].

When eIF2α is phosphorylated at serine 51 by any of these kinases, it forms a stable complex with the guanine nucleotide exchange factor eIF2B[7][28]. This interaction prevents eIF2B-mediated GDP-GTP exchange, thereby blocking the regeneration of active eIF2-GTP ternary complexes required for translation initiation[7]. The consequence is a rapid and dramatic reduction in global protein synthesis as ribosomes lack the activated eIF2-GTP-Met-tRNA complex necessary for scanning initiation codon recognition[7][10]. Remarkably, this global translational shutdown is coupled with a selective activation of ATF4 translation through a translational re-initiation mechanism involving upstream open reading frames (uORFs) in the ATF4 mRNA 5' untranslated region[4][7][10][27][30].

### Translational Control of ATF4 Through uORF-Mediated Re-initiation

The ATF4 mRNA possesses an exceptionally sophisticated translational control mechanism involving two upstream open reading frames (uORF1 and uORF2) located in its 5' untranslated region[4][10][27][30]. Under unstressed conditions when eIF2-GTP ternary complexes are abundant, ribosomes scanning the 5' UTR efficiently recognize and initiate translation at the uORF1 start codon, encode a short polypeptide, and then readily reacquire an eIF2-GTP-Met-tRNA complex in time to reinitiate at the next in-frame uORF2 initiation codon[10][27][30]. Since uORF2 is positioned out-of-frame with the ATF4 coding region, translation of uORF2 terminates upstream of the ATF4 start codon, preventing ATF4 protein synthesis[10][27][30]. Consequently, under basal conditions, ATF4 protein levels are maintained at low levels despite continuous transcription of the ATF4 mRNA.

In contrast, when cells experience stress and eIF2α kinases phosphorylate eIF2α, the concentration of active eIF2-GTP-Met-tRNA ternary complexes drops sharply[7][10][27][30]. Under these reduced ternary complex conditions, ribosomes translating the ATF4 mRNA 5' UTR still efficiently initiate at uORF1 and synthesize the short uORF1 polypeptide[10][27][30]. However, when the scanning ribosome resumes translation after terminating uORF1, it cannot reacquire a new ternary complex rapidly enough at the low ternary complex concentrations, causing it to bypass (re-initiate at) the out-of-frame uORF2 initiation codon and instead scan to and initiate at the downstream ATF4 main coding region[10][27][30]. This mechanism, termed "delayed translation reinitiation," represents a remarkable evolutionary solution where the very same stress signal that shuts down global protein synthesis simultaneously and selectively upregulates ATF4 translation[10][27][30]. The optimal distance between uORF1 and uORF2 is critical to this mechanism—experimental insertion of sequences between these elements that extends the intervening distance prevents efficient ATF4 translation even under stress conditions[30].

## Target Genes and Transcriptional Programming

### Comprehensive Target Gene Networks

ATF4 regulates an extensive network of target genes involved in amino acid metabolism, oxidative stress resistance, autophagy, apoptosis, cell differentiation, angiogenesis, and developmental processes[1][2][6][9][15][18][22][35]. ChIP-sequencing studies in multiple cell types have identified ATF4 binding sites near the promoters of hundreds of genes, and genome-wide transcriptomic analysis combined with ChIP data reveals approximately 1,955 genes that show both ATF4 occupancy and ATF4-dependent differential expression[18][28]. Pathway enrichment analysis of ATF4 target genes demonstrates significant enrichment for processes directly related to stress amelioration and cellular adaptation, including endoplasmic reticulum stress response, amino acid metabolism and synthesis, oxidative stress response, autophagy and mitophagy, and apoptosis[6][15][18].

Among the most extensively characterized ATF4 target genes is **asparagine synthetase (ASNS)**, which catalyzes the synthesis of asparagine from aspartate during amino acid starvation[9][14]. ASNS induction by amino acid deprivation occurs exclusively through the GCN2-eIF2α-ATF4 pathway, as ATF4-deficient cells show completely blocked ASNS induction under amino acid limitation[9]. The ASNS promoter contains C/EBP-ATF response elements (CARE) that serve as amino acid response elements (AARE) recognized by ATF4[9]. ATF4 rapidly translocates to the nucleus within 30-45 minutes of amino acid limitation and associates with the ASNS promoter, with maximal binding occurring around 4 hours, coinciding with peak ASNS transcription[9]. However, sustained amino acid limitation beyond this point results in ATF4-dependent induction of ATF3, C/EBPβ, and CHOP proteins, which subsequently recruit to the ASNS CARE site and progressively suppress ATF4-mediated transcription[9]. This elegant self-limiting mechanism provides temporal control over ASNS expression, preventing indefinite overproduction of the amino acid synthesis enzyme.

Other critical ATF4 target genes include **DNA damage-inducible transcript 3 (DDIT3, encoding CHOP)**, a pro-apoptotic transcription factor induced during prolonged ER stress[18][21]; **tribbles pseudokinase 3 (TRIB3)**, which inhibits the anti-apoptotic kinase Akt[18]; **C/EBP family members** including C/EBPβ, C/EBPγ, and C/EBPδ[18]; **autophagy-related genes (ATG genes)** including ATG9, ATG12, ATG101, and others that comprise the autophagic machinery[8]; **oxidative stress response genes** including genes of the **glutathione pathway** such as **cystathionine γ-lyase (CTH)** and the xc− amino acid transporter **solute carrier family 7 member 11 (SLC7A11)**[2][15]; **amino acid transporter genes** including SLC1A4, SLC38A2, SLC3A2, and others involved in system A, ASC, L, N, T, and xc− transport systems[2][42]; and **protein phosphatase 1 regulatory subunit 15A (PP1R15A, also known as GADD34)**, which provides negative feedback by dephosphorylating eIF2α, thereby terminating the ISR[2][15]. Additionally, ATF4 directly activates **NLRP1 inflammasome component** expression during ER stress, establishing a direct mechanistic link between ER stress and inflammasome-mediated innate immunity[31][34].

### Stress-Dependent Target Gene Selection

The specific subset of ATF4 target genes activated in response to a particular stress stimulus is highly dependent on the stress type, cellular context, and the particular combinations of ATF4 dimerization partners present[11][18][28]. For example, during amino acid starvation induced through GCN2 activation, ATF4 preferentially regulates genes involved in amino acid synthesis and transport, promoting cellular adaptation to the nutrient limitation[9][42]. In contrast, when ER stress activates the ISR through PERK-mediated eIF2α phosphorylation, ATF4 instead coordinately activates both adaptive genes including protein chaperones and genes encoding ERAD machinery components (which are shared with amino acid starvation responses), but also uniquely activates XBP1 and ATF6, other principal UPR transcription factors[11][15]. The duration and intensity of the stress also critically determines whether ATF4 drives a pro-survival transcriptional program or a pro-apoptotic one[11][18][28]. Low-intensity or brief ISR activation preferentially induces survival-promoting genes involved in stress amelioration and cellular recovery[11]. However, if stress is severe in intensity or prolonged in duration, overwhelming the cell's adaptive capacity, ATF4 cooperates with CHOP to activate pro-apoptotic target genes including **BCL2-interacting mediator of cell death (BIM)**, **p53 upregulated modulator of apoptosis (PUMA)**, **Noxa**, and others that trigger programmed cell death[11][18][28].

## Regulation of ATF4 Through Post-Translational Modification

### Phosphorylation and Activity Enhancement

ATF4 is subject to extensive post-translational modifications that modulate its transcriptional activity, protein stability, subcellular localization, and ability to form productive heterodimeric complexes[11][28][52][57]. Phosphorylation represents one of the most significant regulatory PTM for ATF4, occurring at multiple serine and threonine residues throughout both the TAD and bZip domains[11][28][57]. Casein kinase 2 (CK2) phosphorylates ATF4 at serine 215 within the TAD, and this phosphorylation significantly enhances ATF4 transcriptional activity[11][28][52]. Mutation of serine 215 to alanine (S215A) substantially reduces reporter activity driven by amino acid response elements or the ATF3 promoter[11][28][52]. Importantly, mutagenesis studies demonstrated that only the bZip alpha helix of ATF4 is highly ordered, with CK2 requiring the bZip domain structure to phosphorylate ATF4 in the otherwise disordered transactivation domain region[11][28][52].

Another significant phosphorylation occurs at serine 219, which is critical for recognizing ATF4 as a substrate for proteasomal degradation[11][25][28][52]. This phosphorylation is catalyzed by glycogen synthase kinase 3 (GSK3), particularly in pancreatic β-cells[11][28][52]. The functional significance of this phosphorylation became apparent when researchers discovered that insulin signaling, which inhibits GSK3, resulted in unexpected ATF4 upregulation in pancreatic cells[11][28][52]. This regulatory relationship connects insulin/glucose sensing to ATF4 activity, potentially allowing cells to couple nutrient sensing through insulin signaling with stress response pathways. Additionally, the RET kinase phosphorylates ATF4 at threonine residues 107, 114, 115, and 119, which reduces transcription of pro-apoptotic target genes NOXA and PUMA, though it remains unclear whether this represents a general reduction in ATF4 transcriptional activity or specific suppression of pro-apoptotic targets[11][28][52].

### Ubiquitination and Proteasomal Degradation

The SCF^βTRCP^ E3 ubiquitin ligase complex mediates phosphorylation-dependent ubiquitination and proteasomal degradation of ATF4[11][25][28][52][57]. The β-transducin repeat-containing protein (βTRCP) component of this complex recognizes the motif DSGXXXS located at ATF4 serine residues 219 and 224, a recognition sequence similar to those found in other SCF^βTRCP^ substrates including IκBα and β-catenin[25]. The F-box-deleted βTRCP protein acts as a dominant-negative inhibitor that prevents ATF4 ubiquitination and degradation, resulting in enhanced ATF4 stability and increased activity in cyclic AMP-mediated transcription[25]. The in vivo ubiquitination assay revealed that presence of wild-type βTRCP significantly enhances ATF4 ubiquitination, with higher-molecular-weight polyubiquitinated forms detected only upon longer exposure, suggesting that ATF4 may be preferentially targeted for monoubiquitination rather than traditional polyubiquitin chain-mediated proteasomal degradation[25]. The protein EP300 histone acetyltransferase associates with ATF4's N-terminal region to prevent ubiquitination, operating independently of EP300's acetylation catalytic activity, suggesting that physical binding of EP300 to ATF4 sterically blocks N-terminal ubiquitination sites[11][28][57].

Several E3 ubiquitin ligase adaptor proteins have been identified as ATF4-interacting proteins, including ASB7 (ankyrin repeat and SOCS box-containing protein 7) and MDM2, which may participate in ubiquitinating ATF4 at N-terminal sites[11][28][57]. These regulatory mechanisms suggest that ATF4 protein abundance is tightly controlled through a balance between stabilization by certain proteins (EP300) and degradation promoted by others (βTRCP, potentially ASB7, and MDM2), allowing cells to rapidly adjust ATF4 protein levels in response to changing cellular conditions and the need for stress response activation or termination.

### Other Post-Translational Modifications

Beyond phosphorylation and ubiquitination, ATF4 undergoes several other PTMs including SUMOylation at lysine residues 45 and 53, which can compete with ubiquitination at the same sites, potentially regulating whether ATF4 is ubiquitinated for degradation or SUMOylated for altered function[11][28][57]. Acetylation of ATF4 has also been detected in multiple studies, though the specific lysine residues modified and the functional consequences of acetylation remain to be fully elucidated[11][28][57]. These multiple PTMs at distinct sites within ATF4 provide numerous regulatory nodes through which cellular signaling cascades can modulate ATF4 activity, explaining the plasticity in ATF4 function across different stress contexts and cellular types.

## Dimerization Partners and Transcriptional Specificity

### The bZIP Heterodimer Family

Twenty-seven bZIP transcription factors have been identified and verified as direct ATF4-interacting heterodimerization partners through techniques including Förster resonance energy transfer (FRET) measurements of purified proteins[11][28][57]. These include multiple members of the C/EBP family (C/EBPα, C/EBPβ, C/EBPγ, C/EBPδ), ATF family members (ATF3, ATF5, ATF6), AP-1 family members (c-Jun, c-Fos, Fra1, Fra2), and others[11][28][57]. The specific ATF4 heterodimer that forms substantially influences both the set of target genes activated and the magnitude of transcriptional response[11][18][28]. For instance, ATF4-CHOP heterodimers are particularly effective at activating pro-apoptotic genes during prolonged ER stress[11][18], while ATF4-C/EBPβ heterodimers preferentially regulate amino acid metabolic genes during nutrient stress[9]. ATF4-ATF3 heterodimers were found to bind and upregulate the pro-apoptotic protein NOXA/PMAIP1[10][18].

The CREB3L2-ATF4 heterodimer has recently emerged as particularly important in neurodegenerative disease contexts, specifically in Alzheimer's disease pathogenesis[26]. In this pathway, amyloid-beta 42 (Aβ42), an early trigger of Alzheimer's disease pathogenesis, potentiates the heterodimerization of CREB3L2 with ATF4[26]. Using a novel chemogenetic methodology termed ChIPmera (developed to resolve the genomic binding patterns of specific dimeric transcription factors), researchers demonstrated that the CREB3L2-ATF4 heterodimer regulates a transcription network that interacts with approximately half of the genes differentially expressed in Alzheimer's disease, including genes associated with β-amyloid and tau neuropathologies[26]. Importantly, this heterodimer triggers characteristic cellular features of Alzheimer's disease including tau hyperphosphorylation, a primary driver of neurodegeneration in the condition[26].

### Interaction with Co-regulatory Proteins

Beyond heterodimerization with other bZIP transcription factors, ATF4 physically interacts with several non-bZIP proteins that modulate its function[11][28][57]. The pseudokinase TRIB3 directly interacts with ATF4 and inhibits its transcriptional activity, as well as that of CHOP and C/EBPβ[18][28]. The chromatin architecture regulator CTCF has been identified as an ATF4-interacting protein, and this interaction may confer additional plasticity to the genome to facilitate large-scale reorganization of the transcriptome during stress[18][28]. In neurons, the DISC1 (disrupted in schizophrenia 1) protein binds ATF4 and inhibits its transcription factor activity by disrupting ATF4 dimerization and DNA-binding capability[21][28]. This interaction appears particularly important for regulating synaptic plasticity and long-term memory, as DISC1 acts as a regulator of synaptic functions by preventing ATF4-mediated transcription[21]. The DAPK3 (death-associated protein kinase 3) protein also interacts with ATF4, with evidence suggesting that ATF4 dimerization with DAPK3 prevents DAPK3 homodimerization and thereby inhibits its kinase activity-dependent apoptosis induction[18].

## Cellular Localization and Nuclear Dynamics

### Subcellular Distribution and Nuclear Trafficking

ATF4 functions exclusively as a nuclear transcription factor, requiring proper trafficking to the nucleus to execute its transcriptional roles[14][17][21]. A nuclear localization sequence (NLS) has been identified within the C-terminal region of the ATF4 protein[14]. Early observations suggested that endogenous ATF4 undergoes rapid translocation to the nucleus following synthesis during stress conditions[14]. However, subsequent experimentation revealed that ATF4 trafficking to the nucleus does not require additional signals from the integrated stress response pathway itself—ectopically expressed ATF4 protein accumulates predominantly in the nuclear compartment even in the absence of stress and without activation of the eIF2α phosphorylation cascade[14]. This indicates that the NLS within ATF4 is sufficient for constitutive nuclear localization, and that the stress-responsive element in ATF4 regulation is primarily translational rather than translocation-dependent[14]. The nuclear localization of ATF4 appears to occur rapidly, as most newly synthesized ATF4 protein localizes to the nucleus within minutes of synthesis[14]. ATF4 associates with chromatin and exists within protein-containing complexes and nuclear speck structures, indicating that it maintains stable interactions with other transcriptional and regulatory machinery[17][24][28].

### Nuclear Dynamics During Stress

During amino acid starvation or ER stress, ATF4 binds to the promoters and enhancers of target genes with kinetics that reflect the stress intensity and duration[9]. ChIP analysis demonstrated that ATF4 binding to the ASNS gene promoter peaks at approximately 4-6 hours of amino acid starvation, with binding gradually declining between 4 and 24 hours as feedback regulatory proteins including ATF3, C/EBPβ, and CHOP accumulate and compete for binding sites[9]. Circadian regulation represents an additional layer of ATF4 nuclear dynamics—ATF4 binds in a circadian time-dependent manner to CRE elements in the promoters of the core clock component PER2 and the serotonin transporter SLC6A4, periodically activating their transcription in a time-of-day-dependent manner[2][21][24].

## Role in Cellular Adaptation and Metabolic Processes

### Amino Acid Metabolism and Synthetic Capacity

ATF4 serves as the master regulator of amino acid biosynthesis and cellular amino acid homeostasis during nutrient stress[2][8][9]. During amino acid deprivation, ATF4 upregulates expression of amino acid biosynthetic enzymes and amino acid transporter proteins to increase intracellular amino acid availability[2][8][9]. The asparagine synthetase (ASNS) gene represents the paradigmatic example, with ATF4 binding to AARE sequences and robustly activating transcription in response to amino acid limitation[9]. In amino acid-deprived cancer cells or tumors in nutrient-poor microenvironments, ATF4-dependent ASNS upregulation maintains cellular asparagine levels, enabling continued protein synthesis and cell survival[9][35]. Similarly, ATF4 directly activates transcription of amino acid transporter genes from multiple transport systems, increasing the cellular capacity to capture available amino acids from the extracellular environment[2][42]. The ATF4-dependent amino acid transporter reprogramming has been particularly well-characterized in the context of tryptophan deprivation, where ATF4 upregulates expression of SLC1A5, SLC7A11, and SLC1A4 to enhance transport of glutamine, cystine, and other amino acids that can compensate for tryptophan limitation[39].

### Oxidative Stress Response and Redox Homeostasis

Beyond amino acid metabolism, ATF4 is crucial for cellular adaptation to oxidative stress through upregulation of antioxidant genes and redox-balancing pathways[2][15][21]. ATF4 transcriptionally activates the glutathione biosynthetic pathway by inducing expression of multiple enzymes including cystathionine γ-lyase (CTH) and glutamate-cysteine ligase catalytic subunit (GCLC)[15]. Glutathione (GSH), the product of these biosynthetic pathways, serves as the critical reducing substrate for glutathione peroxidase 4 (GPX4), the key enzyme protecting cells from ferroptotic cell death[15][41]. Additionally, ATF4 regulates expression of system xc− amino acid transporters (SLC7A11 and SLC3A2) that mediate cystine/glutamate exchange, thereby maintaining cystine uptake which is required for glutathione synthesis[2][15][39]. This multifaceted ATF4-dependent regulation of redox homeostasis represents a critical adaptation to oxidative stress, linking amino acid transport, amino acid biosynthesis, and antioxidant enzyme expression into a coordinated transcriptional program.

### Autophagy and Mitochondrial Function

ATF4 orchestrates the induction of autophagy during amino acid starvation and ER stress through direct transcriptional activation of multiple autophagy-related genes (ATG genes)[8]. The eIF2α-ATF4 pathway directs a comprehensive autophagy gene transcriptional program by binding to AARE sequences in the promoters of genes including ATG9, ATG12, ATG101, and many others encoding components of the autophagosome biogenesis, elongation, and function machinery[8]. ATF4 and CHOP function cooperatively to increase transcription of the autophagy adaptor protein p62/SQSTM1, with both transcription factors binding AARE sequences in the p62 promoter[8]. The ATF4-dependent induction of autophagy during nutrient deprivation represents an adaptive response allowing cells to degrade intracellular components for amino acid recycling and energy production, supporting survival during prolonged nutrient limitation.

During ER stress, ATF4 also plays a critical role in regulating mitochondrial function and bioenergetics[55]. The PERK-eIF2α-ATF4 axis specifically increases expression of supercomplex assembly factor 1 (SCAF1, also designated COX7A2L), which promotes formation of respiratory chain supercomplexes and enhances mitochondrial oxidative phosphorylation[55]. This ATF4-mediated increase in mitochondrial energetic capacity appears particularly important for providing the ATP required for active unfolded protein response and protein synthesis recovery during ER stress[55]. Additionally, ATF4 activates transcription of mitochondrial chaperone proteins including the mitochondrial heat shock protein 70 (HSPA9) and proteases such as the AAA+ protease LON, which enhance mitochondrial protein quality control and proteostasis capacity[40]. Some ATF4 target genes localize to the mitochondria and regulate apoptosis signaling, including the chaperone DNAJA3/TID1 which exists in both long and short isoforms with opposing roles in apoptosis regulation[18].

## Tissue-Specific and Developmental Functions

### Bone Development and Osteoblast Differentiation

ATF4 plays indispensable roles in skeletal development and bone homeostasis through its expression in osteoblasts[20][50][53][56][59]. Global ATF4 deletion in mice results in severe osteopenia, impaired osteoblast terminal differentiation, reduced osteocalcin (OCN) expression, and decreased type I collagen synthesis[20][50]. The *Atf4* null mouse skeleton exhibits a characteristically smaller size due to reduced cartilage growth and delayed ossification center formation[20]. Conditional genetic approaches revealed that ATF4 operates through distinct cell-autonomous functions in both chondrocytes and osteoblasts. In chondrocytes, ATF4 regulates expression of Indian hedgehog (Ihh), a paracrine signaling molecule that controls proliferation of prechondrogenic cells and stimulates osteoblast differentiation in the adjacent perichondrium[20]. Atf4 null chondrocytes exhibit reduced Ihh expression and impaired hedgehog signaling, leading to secondary defects in osteoblast differentiation and bone collar formation[20]. Through selective overexpression of Atf4 in chondrocytes of otherwise Atf4-null mice, the full bone formation phenotype can be rescued, demonstrating that chondrocyte-derived Atf4 dominates in controlling early osteogenesis during skeletal development[20].

In mature osteoblasts, ATF4 functions as a critical regulator during terminal differentiation and matrix mineralization[50][53][56][59]. ATF4 acts as a substrate for the ribosomal S6 kinase RSK2 (encoded by RPS6KA3), and this phosphorylation substantially enhances ATF4 transactivation activity and promotes expression of osteoblast-specific genes including osteocalcin (BGLAP), osteopontin (SPP1/IBSP), alkaline phosphatase (ALP), and type I collagen (COL1A1)[50][53]. Importantly, ATF4 post-transcriptionally regulates the synthesis of type I collagen, the main constituent of the bone matrix, through mechanisms that remain to be fully elucidated[50][53]. The cooperation between ATF4 and the master osteogenic transcription factor RUNX2 represents a key regulatory axis, with RUNX2 promoting expression of ATF4, which then acts downstream to amplify osteoblast differentiation signals[50][53].

ATF4 and the FOXO1 transcription factor cooperate in osteoblasts to regulate glucose homeostasis, with implications extending far beyond bone itself[56][59]. Both FoxO1 and ATF4 suppress osteocalcin activity through upregulating expression of protein tyrosine phosphatase (encoded by Esp), which inactivates osteocalcin through carboxylation[56][59]. This FoxO1/ATF4-mediated suppression of osteocalcin bioactivity decreases insulin secretion from pancreatic β-cells and reduces insulin sensitivity in liver, adipose tissue, and muscle[56][59], thereby increasing blood glucose levels and decreasing glucose tolerance[56][59]. Genetic models demonstrate that FoxO1 and ATF4 cooperate synergistically in this regulatory pathway—compound heterozygous *FoxO1*^+/−^*;Atf4*^+/−^ mice with single allele deletions of both genes show metabolic phenotypes similar to complete knockouts of either factor alone[56]. This reveals an elegant cross-talk between bone and systemic energy metabolism, with osteoblast-expressed ATF4 contributing critically to whole-body glucose homeostasis.

### Lens Development and Maintenance

ATF4 is essential for the survival and function of the avascular lens, which relies entirely on diffusion for nutrient delivery and depends critically on amino acid and glutathione availability[45][48]. *Atf4* null embryos exhibit severe lens defects starting in late embryonic development, with complete lens disintegration observed by birth due to epithelial and/or fiber cell apoptosis[45][48]. The mechanism underlying this developmental requirement involves ATF4's role in regulating nutrient transport and biosynthesis genes critical for lens cell survival in its avascular environment[45]. RNA-sequencing analysis of *Atf4* null lenses revealed enrichment for genes involved in nutrient transport, amino acid biosynthesis, and tRNA charging[45]. These changes result in marked reductions in lens free amino acid and glutathione levels, leading to diminished extractable lens protein and ultimately lens disintegration[45]. The lens epithelial cells in *Atf4* null lenses show dramatically reduced proliferation rates—fewer than 20% of null lens epithelial cells are actively cycling compared to over 50% in wildtype lenses[45]. This demonstrates that ATF4, through its integrated stress response functions, is critical for mediating lens cell adaptation to the metabolic constraints imposed by avascularity and maintaining the optical transparency necessary for vision.

### Hematopoiesis and Immune Function

ATF4 plays important roles in hematopoietic stem cell (HSC) homeostasis and immune cell development[23][32]. ATF4 deficiency leads to aging-like attrition of adult hematopoietic stem cells, characterized by functional defects including reduced repopulating and self-renewal capacities and myeloid differentiation bias[23]. ATF4-deficient HSCs show phenotypic expansion with increased frequencies of long-term HSCs, reminiscent of aged hematopoietic stem cell populations, indicating that ATF4 normally acts to prevent HSC aging-related alterations[23]. This ATF4-dependent regulation of HSC aging involves control of mitochondrial reactive oxygen species production through targeting HIF1α[23]. Mechanistically, loss of ATF4 in HSCs leads to elevated mitochondrial ROS production, compromising the self-renewal and repopulating capacity of these cells[23]. ATF4 also regulates CD4+ T cell immune responses through metabolic reprogramming, controlling the expression of genes involved in amino acid intake, mTORC1 activation, protein translation, and de novo amino acid synthesis[32]. ATF4-deficient CD4+ T cells show defects in redox homeostasis, proliferation, differentiation, and cytokine production[32]. ATF4-deficient mice mount reduced Th1 but elevated Th17 immune responses and develop more severe experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis[32]. These findings establish ATF4 as a critical regulator of both innate hematopoietic stem cell function and adaptive immune cell differentiation and function.

## Role in Cancer and Metabolic Reprogramming

### Amino Acid Metabolism in Cancer

ATF4 is frequently upregulated in cancer cells and tumors, and emerging evidence indicates that ATF4 plays complex roles in cancer progression through regulation of amino acid metabolism and metabolic reprogramming[22][35]. In numerous cancer types, ATF4-mediated upregulation of amino acid biosynthetic enzymes including asparagine synthetase and phosphoserine aminotransferase 1 (PSAT1) enables cancer cells to synthesize amino acids de novo when exogenous supply is limited[22][35]. This ATF4-dependent amino acid biosynthetic capacity is particularly important in nutrient-poor tumor microenvironments where certain amino acids become limiting. PSAT1 represents a critical downstream target of ATF4 in estrogen receptor-negative breast cancer, where ATF4-dependent PSAT1 upregulation enhances cell proliferation through the GSK3β/β-catenin/cyclin D1 signaling pathway[22]. In gastric cancer, ATF4 has been found to participate in cancer initiation and progression through multiple mechanisms, including direct activation of the Sonic Hedgehog pathway (through binding to the SHH promoter) and upregulation of CHAC1 glutathione-specific γ glutamylcyclotransferase to degrade glutathione and mediate ferroptosis[22].

### Metabolic Adaptation and Ferroptosis Resistance

Paradoxically, while ATF4-mediated amino acid biosynthesis can support tumor growth in certain contexts, loss of ATF4 can increase susceptibility to ferroptosis and impair tumor development in others[22]. This dual role likely depends on the specific metabolic context and the particular cancer type. In hepatocellular carcinoma (HCC), ATF4 directly targets SLC7A11 (encoding the xc− amino acid transporter) to sustain glutathione synthesis and prevent ferroptosis-dependent cell death[22]. Therefore, ATF4 ablation could increase HCC susceptibility to ferroptosis and potentially impair tumorigenesis[22]. In glioblastoma, ATF4 modulates metabolic reprogramming, integrated stress response, and ferroptosis regulation to promote disease progression[22]. ATF4 can promote ferroptosis-mediated cell death and tumor angiogenesis in glioma, effects that are attenuated by xCT (SLC7A11) inhibition and can be further abrogated by the ferroptosis inducer erastin[22]. Thus, ATF4 ablation has been proposed as a promising target for suppressing glioma growth and vasculature by sensitizing glioma cells to ferroptosis[22].

### Metabolic Cooperation and One-Carbon Pathway

In castration-resistant prostate cancer (CRPC), loss of the protein kinase C iota/lambda (PKCλ/ι) activates mTORC1 to induce an ATF4-mediated transcriptional program, leading to metabolic adaptation of CRPC cells to elevate the flux through the one-carbon pathway[22]. This metabolic reprogramming driven by PKCλ/ι loss and ATF4 activation appears to provide selective growth advantages to CRPC cells. These findings demonstrate that ATF4 functions at the hub of a complex metabolic reprogramming network in cancer, and that the outcome (tumor promotion or suppression) depends on the interplay between ATF4 activation and other metabolic signaling pathways operating in the specific cancer type.

## Clinical Significance and Disease Associations

### Neurodegenerative Diseases

Recent research has highlighted ATF4's role in Alzheimer's disease pathogenesis through its interaction with CREB3L2, as discussed above[26]. The CREB3L2-ATF4 heterodimer transcriptionally regulates genes involved in cellular proteostasis and protein trafficking, and dysregulation of this axis may contribute to the protein aggregation and tau hyperphosphorylation characteristic of Alzheimer's disease[26]. Additionally, ATF4 has been implicated in other neurodegenerative conditions through its role in regulating synaptic plasticity and long-term memory[21][28]. ATF4 normally acts as a repressor of synaptic plasticity, inhibiting the induction and maintenance of long-term memory through its interaction with DISC1, which disrupts ATF4 dimerization and DNA binding[21][28]. This repressive role of ATF4 in memory formation appears to be a conserved function, as ATF4 in C. elegans (where the IMPACT protein regulates ATF4) has been shown to promote lifespan extension[4][21].

### Skeletal Disorders and Bone Disease

The critical role of ATF4 in osteoblast differentiation and bone homeostasis places it at the center of several skeletal disorders[50][53]. Mutations or dysregulation of ATF4 or its upstream regulators can lead to impaired bone formation and osteopenia[50][53]. The discovery that ATF4 cooperates with FOXO1 to regulate glucose homeostasis through osteoblasts has opened new perspectives on the skeletal contributions to metabolic diseases including obesity and diabetes[56][59]. Understanding ATF4 regulation in osteoblasts may provide new therapeutic opportunities for treating metabolic disorders through bone-targeted interventions.

### Metabolic Diseases

ATF4's role in regulating glucose homeostasis through osteoblast expression indicates that ATF4 dysregulation may contribute to metabolic diseases[56][59]. The discovery of insulin signaling-dependent ATF4 upregulation through GSK3 inhibition suggests that ATF4 may serve as a link between nutrient sensing (via insulin signaling) and stress response pathways[11][28][52]. This positioning of ATF4 at the interface of nutrient sensing and stress responses may make it an important regulator in metabolic disease contexts where cells experience combined nutritional and metabolic stress.

## Conclusion

Activating Transcription Factor 4 (ATF4) represents a masterfully evolved cellular regulatory hub that coordinates diverse aspects of mammalian physiology ranging from acute cellular stress adaptation to long-term developmental processes and systemic metabolic homeostasis. The intricate molecular mechanisms underlying ATF4 function—including its sophisticated translational control through upstream open reading frames, its context-dependent heterodimerization with numerous bZIP partners, its extensive post-translational modifications, and its selective target gene activation—exemplify how cells achieve remarkable specificity and plasticity in gene regulation using relatively simple molecular components. ATF4's dual functionality as both a basal metabolic regulator essential for normal development and tissue homeostasis, and a stress-responsive transcription factor capable of both cell survival and cell death decisions, demonstrates the evolutionary success of this protein as a central molecular decision point in cellular physiology. The extensive research into ATF4 function has revealed its involvement in virtually every major cellular and organismal process including amino acid metabolism, oxidative stress response, autophagy, apoptosis, development, hematopoiesis, immune function, bone homeostasis, energy metabolism, and disease pathogenesis. Future research directions include clarifying the precise molecular mechanisms underlying ATF4's role in specific diseases, understanding how ATF4 coordinates with other stress-response pathways at the systems level, developing therapeutic strategies to modulate ATF4 activity for disease treatment, and elucidating the full spectrum of ATF4 target genes and their functional relationships. The continuing discovery of new ATF4 interaction partners, target genes, and regulatory modifications indicates that despite decades of research, fundamental aspects of ATF4 biology remain to be uncovered, promising continued insights into how this elegant transcription factor orchestrates cellular adaptation and survival.

## Citations

1. https://pubmed.ncbi.nlm.nih.gov/17466566/
2. https://www.genecards.org/cgi-bin/carddisp.pl?gene=ATF4
3. https://pubs.acs.org/doi/10.1021/acs.biochem.4c00640
4. https://en.wikipedia.org/wiki/ATF4
5. https://www.ncbi.nlm.nih.gov/gene?Db=gene&Cmd=DetailsSearch&Term=468
6. https://pmc.ncbi.nlm.nih.gov/articles/PMC10637723/
7. https://pmc.ncbi.nlm.nih.gov/articles/PMC5048378/
8. https://academic.oup.com/nar/article/41/16/7683/2411270
9. https://journals.physiology.org/doi/full/10.1152/ajpendo.00015.2013
10. https://www.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2023.1112253/full
11. https://pmc.ncbi.nlm.nih.gov/articles/PMC9941348/
12. https://pubmed.ncbi.nlm.nih.gov/18940792/
13. https://pmc.ncbi.nlm.nih.gov/articles/PMC2755847/
14. https://pmc.ncbi.nlm.nih.gov/articles/PMC4850040/
15. https://pmc.ncbi.nlm.nih.gov/articles/PMC1592802/
16. https://www.proteinatlas.org/ENSG00000128272-ATF4/subcellular
17. https://pmc.ncbi.nlm.nih.gov/articles/PMC4391610/
18. https://pmc.ncbi.nlm.nih.gov/articles/PMC3252356/
19. https://olink.com/assay/explore/oncology-ii/cyclic-amp-dependent-transcription-factor-atf-4
20. https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2024.1370012/full
21. https://www.science.org/doi/10.1126/sciadv.abj6877
22. https://go.drugbank.com/polypeptides/P18848
23. https://pmc.ncbi.nlm.nih.gov/articles/PMC86853/
24. https://www.science.org/doi/10.1126/sciadv.add2671
25. https://pmc.ncbi.nlm.nih.gov/articles/PMC5016099/
26. https://www.pnas.org/doi/10.1073/pnas.0400541101
27. https://pmc.ncbi.nlm.nih.gov/articles/PMC4472728/
28. https://pubmed.ncbi.nlm.nih.gov/29742431/
29. https://genesdev.cshlp.org/content/7/6/1047
30. https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0130635
31. https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.740120/full
32. https://pubmed.ncbi.nlm.nih.gov/7500340/
33. https://pubmed.ncbi.nlm.nih.gov/36825279/
34. https://pmc.ncbi.nlm.nih.gov/articles/PMC10982331/
35. https://aacrjournals.org/cancerres/article/76/21/6193/613830/Nutritional-Stress-Induced-by-Tryptophan-Degrading
36. https://elifesciences.org/reviewed-preprints/100541
37. https://journals.physiology.org/doi/full/10.1152/physrev.00031.2024
38. https://pmc.ncbi.nlm.nih.gov/articles/PMC5292668/
39. https://pmc.ncbi.nlm.nih.gov/articles/PMC4335802/
40. https://pmc.ncbi.nlm.nih.gov/articles/PMC10670291/
41. https://ashpublications.org/blood/article-abstract/103/5/1876/18221
42. https://pmc.ncbi.nlm.nih.gov/articles/PMC8444148/
43. https://iovs.arvojournals.org/article.aspx?articleid=2773942
44. https://pmc.ncbi.nlm.nih.gov/articles/PMC12394429/
45. https://www.ncbi.nlm.nih.gov/gene/468
46. https://www.uniprot.org/citations/15109498
47. https://www.uniprot.org/uniprotkb/P18848/entry
48. https://pubmed.ncbi.nlm.nih.gov/31023583/
49. https://pmc.ncbi.nlm.nih.gov/articles/PMC3308768/
50. https://www.uniprot.org/uniprotkb/O14548/entry
51. https://www.jci.org/articles/view/39901
52. https://pmc.ncbi.nlm.nih.gov/articles/PMC11924230/